Previous 10 | Next 10 |
Fluidigm Corporation (FLDM) Q2 2021 Earnings Conference Call August 5, 2021 05:00 PM ET Company Participants Peter DeNardo - Investor Relations Chris Linthwaite - President & Chief Executive Officer Vikram Jog - Chief Financial Officer Conference Call Participants Sung Ji Nam - BTIG Prese...
Fluidigm (NASDAQ:FLDM): Q2 Non-GAAP EPS of -$0.12 misses by $0.03; GAAP EPS of -$0.23 misses by $0.03. Revenue of $31.02M (+19.0% Y/Y) in-line. Press Release For further details see: Fluidigm EPS misses by $0.03, revenue in-line
Base business rebounds. Promising early reception to 4th generation mass cytometry instrument. Services business achieves quarterly revenue record of $6.6 million. SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative ...
Fluidigm (FLDM -0.3%) and Ultivue announce a co-marketing agreement to offer customers a comprehensive portfolio of workflow solutions for biomarker discovery and drug development. The collaboration provides researchers with end-to-end service capability for clinical and translational work. C...
Ultivue, Inc. and Fluidigm Corporation (Nasdaq:FLDM) today announced a co-marketing agreement in which the companies will offer customers a comprehensive portfolio of workflow solutions for biomarker discovery and drug development. Ultivue , a leader in advancing precision medic...
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration and co-marketing agreement with ImaBiotech for se...
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a co-marketing agreement with Ultivue, Inc., under which the comp...
After four back-to-back sessions of gains, the healthcare stocks in the S&P 500 finished ~0.5% higher this week to outperform the ~0.4% loss recorded by the broader index over the past five-day period. A major industry event on Alzheimer’s disease dominated heal...
Fluidigm (NASDAQ:FLDM) pared some gains, now up 0.9%, on a report that interest for the Covid-19 test maker has so far been muted. Fluidigm is said to have hired Jefferies to gauge interest of possible acquirers, according to a CTFN report. The timing of a sale makes sense at this point as Co...
Bit Digital (BTBT) +39%.Infinity Pharmaceuticals (INFI) +42%.Support.com (SPRT) +36%.Grove (GRVI) +25%.Taoping (TAOP) +24% on proposing to acquire 51% stake in Zhenjiang TaopingThe9 (NCTY) +13%.China Natural Resources (CHNR) +14%.ATA Creativity (AACG) +14%.TAL Education ( TAL) ...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...